Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PharmaCyte Biotech (PMCB) Exchange Rate Effect (2016 - 2026)

PharmaCyte Biotech (PMCB) has disclosed Exchange Rate Effect for 11 consecutive years, with -$381.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect fell 724.59% to -$381.0 in Q4 2025 year-over-year; TTM through Oct 2025 was -$860.0, a 198.17% decrease, with the full-year FY2025 number at -$358.0, up 29.53% from a year prior.
  • Exchange Rate Effect was -$381.0 for Q4 2025 at PharmaCyte Biotech, down from $123.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $3544.0 in Q2 2022 to a low of -$5276.0 in Q2 2023.
  • A 5-year average of -$112.15 and a median of $92.0 in 2024 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: skyrocketed 459.87% in 2022, then tumbled 1116.19% in 2023.
  • PharmaCyte Biotech's Exchange Rate Effect stood at $2906.0 in 2021, then tumbled by 124.78% to -$720.0 in 2022, then plummeted by 120.97% to -$1591.0 in 2023, then surged by 103.83% to $61.0 in 2024, then crashed by 724.59% to -$381.0 in 2025.
  • Per Business Quant, the three most recent readings for PMCB's Exchange Rate Effect are -$381.0 (Q4 2025), $123.0 (Q3 2025), and $617.0 (Q2 2025).